Atopic Dermatitis (AD) is a chronic skin condition affecting more than 230 million people globally. Characterized by inflamed, itchy, and dry skin, it can significantly impact both physical and mental well-being. While it commonly starts in childhood, AD can persist or recur throughout life, making long-term management essential.

Scarletred®Vision has been instrumental in advancing research and treatment for atopic dermatitis. This patented medical software allows for precise tracking of skin changes, enabling healthcare professionals and researchers to assess treatment effectiveness and monitor disease progression with clinical-grade accuracy.

By combining digital dermatology with innovative imaging technology, Scarletred®Vision not only improves patient care but also plays a crucial role in enhancing our understanding of AD and its treatments.

For more insights on how Scarletred®Vision supports the fight against atopic dermatitis, read more about it on our website.